GEP20196952B - Substituted quinolizine derivatives useful as hiv integrase inhibitors
- Google Patents
Substituted quinolizine derivatives useful as hiv integrase inhibitors
Info
Publication number
GEP20196952B
GEP20196952BGEAP201414124AGEAP2014014124AGEP20196952BGE P20196952 BGEP20196952 BGE P20196952BGE AP201414124 AGEAP201414124 AGE AP201414124AGE AP2014014124 AGEAP2014014124 AGE AP2014014124AGE P20196952 BGEP20196952 BGE P20196952B
Authority
GE
Georgia
Prior art keywords
derivatives useful
hiv integrase
integrase inhibitors
quinolizine derivatives
substituted quinolizine
Prior art date
Application number
GEAP201414124A
Inventor
Sharp & Dohme Corp Merck
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & DohmefiledCriticalMerck Sharp & Dohme
Priority to GEAP201414124ApriorityCriticalpatent/GEP20196952B/en
Publication of GEP20196952BpublicationCriticalpatent/GEP20196952B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compound of formula (I), (I) wherein values of substitutes R1, R2, R3, R4, R5, R9, R10, X, Y are provided in the claims or their pharmaceutically acceptable salt, pharmaceutical composition on a basis thereof, and their usage for prevention or treatment of HIV-infection or AIDS. s Table: 6
GEAP201414124A2013-09-272014-09-26Substituted quinolizine derivatives useful as hiv integrase inhibitors
GEP20196952B
(en)